Sort
48,018 grants matching “immunotherapy”
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
$540,668Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$540,614David Reardon · Brigham And Women'S Hospital · P01 · FY2021 · CA
Circulating biomarkers of clinical response to combination targeted therapies in neuroblastoma
$540,607Kieuhoa Tran Vo · University Of California, San Francisco · R01 · FY2025 · CA
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$540,596Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$540,527Robert J. Canter · University Of California At Davis · U01 · FY2020 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$540,515Iwei Yeh · University Of California, San Francisco · R37 · FY2022 · CA
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
$540,493Eric T Ahrens · University Of California, San Diego · R01 · FY2017 · CA
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$540,466Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2023 · CA
PAG is a novel target in immunotherapy
$540,458Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$540,450Gordon B. Mills · Oregon Health & Science University · U01 · FY2021 · CA
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$540,401John K. Wiencke · University Of California, San Francisco · P50 · FY2020 · CA
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$540,369Lishan Su · University Of Maryland Baltimore · R01 · FY2020 · AI
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$540,293Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Role of bacterial-derived small molecules in immunotherapy
$540,288Christian Jobin · University Of Florida · R01 · FY2025 · CA
Tissue ProcessingSequencing Core
$540,273Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$540,239Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Developing new therapeutic strategies for brain metastasis
$540,115Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$540,114Adam I Marcus · Emory University · P01 · FY2024 · CA
3D Models of Immunotherapy
$540,107David J Mooney · Harvard University · U01 · FY2019 · CA
Basic Medical Research Training in Oncology
$540,089Olufunmilayo I Olopade · University Of Chicago · T32 · FY2022 · CA
High Performance Magnetic Cell Sorting
$540,039Ohio State University · R01 · FY2005 · CA
Baylor College of Medicine Cancer Center
$540,037C Kent Osborne · Baylor College Of Medicine · P30 · FY2015 · CA
Signal transduction and gene induction in lymphocytes
$540,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2019 · AI
Signal transduction and gene induction in lymphocytes
$540,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2022 · AI
Signal transduction and gene induction in lymphocytes
$540,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2021 · AI